NCT07718854
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +20 more
- Locations
-
- Tufts Medical Center Boston, Massachusetts, United States
Clinical trial condition
Adenocarcinoma, Clear Cell
Explore clinical trials studying Adenocarcinoma, Clear Cell. Study availability and eligibility vary by location and protocol.
19 public trials
6 recruiting studies
Adenocarcinoma, Clear Cell trial results
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +23 more
- Locations
-
- Universitätsklinik Innsbruck Innsbruck, Austria
- Cliniques Universitaires St. Luc Brussels, Belgium
- UZ Gent Ghent, Belgium
- Jessa ziekenhuis Hasselt, Belgium
NCT06023862
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +29 more
- Locations
-
- Monash Medical Centre Clayton, Clayton Rd., Australia
- Calvary Mater Newcastle Waratah, Edith Saint, Australia
- Peter MacCallum Cancer Centre Melbourne, Grattan Saint, Australia
- University of Hong Kong Hong Kong, Pok Fu Ram
NCT07072234
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +6 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT05500391
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Aggressive Fibromatosis of Abdominal Wall (Disorder), +33 more
- Locations
-
- CHU Amiens Amiens, France
- Centre François Baclesse Caen, France
- Centre Oscar Lambret Lille, France
NCT04623502
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +29 more
- Locations
-
- University of Texas Southwestern Medical Center Dallas, Texas, United States
Active, not recruiting
BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
NCT03355976
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +28 more
- Locations
-
- University of Illinois Chicago Chicago, Illinois, United States
- Rhode Island Hospital Providence, Rhode Island, United States
- Women & Infants Hospital Providence, Rhode Island, United States
- The Miriam Hospital Providence, Rhode Island, United States
Active, not recruiting
Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma
NCT01582204
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +14 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Active, not recruiting
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
NCT05544929
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenoma, +83 more
- Locations
-
- Massachusetts General Hospital . Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- NYU School of Medicine New York, United States
- University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
Active, not recruiting
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
NCT00565851
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, +51 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States